リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Predictive factors for the diagnosis of coronavirus disease 2019 (Original)」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Predictive factors for the diagnosis of coronavirus disease 2019 (Original)

保阪, 由美子 堀野, 哲也 保科, 斉生 澤木, 賢司 坂本, 洋平 宮島, 真希子 李, 広烈 中拂, 一彦 中澤, 靖 小川, 和男 天野, 克之 村上, 秀友 三村, 秀毅 齋藤, 健 井口, 保之 吉田, 正樹 東京慈恵会医科大学

2021.03.10

概要

Objective: We evaluated patients suspected or confirmed to have coronavirus disease 2019(COVID-19) to determine predictive factors for the diagnosis of COVID-19.

Methods: We conducted a retrospective cohort study at The Jikei University Hospital, Tokyo, Japan. This study included adult patients who underwent medical examination for suspected or confirmed COVID-19 in April and May 2020. We analyzed the clinical characteristics, blood test results, and findings of computed tomography of the chest from the medical record system of the hospital.

Results: Of the 267 patients included in this study, 27 were found to be positive for COVID-19 on reverse transcription polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Of the patients, 128 (47.9%) were men, and the median age was 47 years (interquartile range, 34.5-65). Twenty-two (8.2%) patients had a history of close contact with a COVID-19 patient. The most common symptoms were fever, general malaise, and cough. Multivari-ate analysis with the logistic regression model revealed that close contact, fever for 4 or more days, dysgeusia, and dysosmia were independent predictive factors for reverse transcription polymerase chain reaction test results being positive for SARS-CoV-2.

Conclusion: Patients who have had close contact with a COVID-19 patient, fever for 4 davs or more, dysgeusia, or dysosmia should undergo diagnostic testing for SARS-CoV-2.

論文の公開元へ

参考文献

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-33.

2. Sampathkumar P, Beam E, Breeher LE, O'Horo JC. Precau-tions, utilization of personal protective equipment, and conservation strategies during the COVID-19 pandemic. Mayo Clin Proc. 2020; 95(9S) : S11-S13.

3. Hanson KE, Caliendo AM, Arias CA, Englund JA, Lee MJ, Loeb M, et al. Infectious Diseases Society of America Guidelines on the diagnosis of coronavirus disease 2019. Clin Infect Dis. 2020; ciaa1343.

4. Huang D, Wang T, Chen Z, Yang H, Yao R, Liang Z. A novel risk score to predict diagnosis with coronavirus disease 2019 (COVID-19) in suspected patients: A retrospective, multi-center, observational study. J Med Virol. 2020 Jun 8: 10.1002/ jmv.26143. Epub ahead of print.

5. Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Asso-cation of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020; 10: 806-13.

6. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-20.

7. Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV- 2; COVID-19) : A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020; 15: e0234765.

8. Zhang JJ, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75: 1730-41.

9. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77: 683-90.

10. Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W. Epidemio-logic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis. BMC Infect Dis. 2020; 20: 640.

11. Ministry of Health, Labour and Welfare. Prevention measures against coronavirus disease 2019 (COVID-19). February 25, 2020 version. https: //www.mhlw.go.jp/content/10900000/000607599. pdf. [accessed 2020-10-30]

12. Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, et al. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020; 414: 116884.

13. Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, SeyedAlinaghi SA. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. 2020 Jun 17; 1-6. Epub ahead of print.

14. Mercante G, Ferreli F, De Virgilio A, Gaino F, Bari MD, Colombo G, et al. Prevalence of taste and smell dysfunction in coronavirus disease 2019. JAMA Otolaryngol Head Neck Surg. 2020; 146: 1-6.

15. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19) : a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277 : 2251-61.

16. Roland LI, Gurrola JG 2nd, Loftus PA, Cheung SW, Chang JL. Smell and taste symptom-based predictive model for COVID-19 diagnosis. Int Forum Allergy Rhinol. 2020; 10: 832-8.

17. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020; 95: 834-47.

18. Cheung CKM, Law MF, Lui GCY, Wong SH, Wong RSM. Coronavirus disease 2019 (COVID-19): a hematologist's perspective. Acta Haematologica. 2020 Jul 28: 1-14. Epub ahead of print.

19. Fathi N, Rezaei N. Lymphopenia in COVID-19 : therapeutic opportunities. Cell Biol Int. 2020; 44: 1792-7.

20. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med. 2020; 382 : 2372-4.

21. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19). Radiology. 2020; 295: 715-21.

22. AiT, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. 2020; 296 : E32-E40.

23. Fang I, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19 : comparison to RT-PCR. Radiolo-gy. 2020; 296 : E115-E117.

24. Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis. 2020; 71: 756-61.

25. Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease 2019 (COVID- 19): relationship to duration of infection. Radiology. 2020; 295: 200463.

参考文献をもっと見る